Preclinical News and Research

RSS
MR Solutions to release MR/PET and MR/SPECT scanners at WMIC

MR Solutions to release MR/PET and MR/SPECT scanners at WMIC

microRNA-486 found to be potent tumor-suppressor molecule in lung cancer

microRNA-486 found to be potent tumor-suppressor molecule in lung cancer

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

Columbia University launched three-year Doctor of Medicine program for PhD biological scientists

Columbia University launched three-year Doctor of Medicine program for PhD biological scientists

Cell Therapeutics agrees to sell 15,000 shares of Series 18 Preferred Stock to Quogue Capital

Cell Therapeutics agrees to sell 15,000 shares of Series 18 Preferred Stock to Quogue Capital

Four new pre-clinical drug development projects at NIH develop treatment for rare disease

Four new pre-clinical drug development projects at NIH develop treatment for rare disease

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Research holds promise for developing treatments for retinitis pigmentos

Research holds promise for developing treatments for retinitis pigmentos

High resolution of U‐SPECT/CT system helps perform kinetic analyses of viral spread in vivo

High resolution of U‐SPECT/CT system helps perform kinetic analyses of viral spread in vivo

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

Researchers start Phase I clinical trial of implantable vaccine for treatment of melanoma

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.